Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tri-Service General Hospital (TSGH)
With
AstraZeneca
Age
20–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The participants who were aged from 20 to 65 years and met the diagnosis of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) were eligible for the recruitment to the clinical trial.
They also fulfilled the criteria including having a score of 4 (moderate) or greater on any of the 7 items of the Positive and Negative Syndrome Scale (PANSS) Positive Symptom Subscale and needed to switch from previous antipsychotics due to insufficient efficacy or insufficient tolerability.
You may not be if
Any DSM-IV-TR Axis I disorder other than schizophrenia, except comorbid obsessive-compulsive disorder, anxiety disorder, eating disorders or impulse control disorders if they had been stable and had not been primary focus of treatment over the previous 6 months
An imminent risk of suicide or a danger to self or others
Pregnancy or lactation
Intolerance or lack of response to quetiapine IR
Use of cytochrome P450 3A4 inhibitors or inducers in the 14 days preceding enrolment
Administration of a depot antipsychotic injection within one dosing interval before recruitment
Unstable or inadequately treated medical illness as judged by the investigator.
